Farzana Tausif
Adult Medicine · Sylvania, OHNPI 1174529861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,511, more than ten times the $11 reported in 2019. Among adult medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$351
- Otsuka America Pharmaceutical, Inc.$298
- Neurocrine Biosciences, Inc.$296
- Alkermes, Inc.$254
- Lundbeck LLC$230
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$228
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $351 |
| Otsuka America Pharmaceutical, Inc. | 24 | $298 |
| Neurocrine Biosciences, Inc. | 15 | $296 |
| Alkermes, Inc. | 17 | $254 |
| Lundbeck LLC | 14 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $228 |
| Johnson & Johnson | 9 | $165 |
| Teva Pharmaceuticals USA, Inc. | 7 | $127 |
| Indivior Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $77 |
| Ironshore Pharmaceuticals Inc. | 4 | $75 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Pfizer | 4 | $66 |
| Exact Sciences | 4 | $66 |
| Bioxcel Therapeutics, Inc. | 1 | $56 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Tris Pharma Inc | 3 | $45 |
| GSK | 2 | $35 |
| Phadia US Inc. | 2 | $35 |
| Bayer | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Corium, LLC | 2 | $32 |
| Luye Pharma (USA) Ltd. | 1 | $28 |
| Lilly USA, LLC | 2 | $27 |
| Sage Therapeutics, LLC | 1 | $19 |
| Merck | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Braeburn Inc. | 1 | $15 |
| Novartis | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| AstraZeneca | 1 | $13 |
How this compares
$2,881 in reported general payments places this provider in the 90th percentile of 22 adult medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $1,134 |
| Atorvastatin Calcium | 24 | $312 |
| Levothyroxine Sodium | 22 | $204 |
| Omeprazole | 22 | $175 |
| Amlodipine Besylate | 19 | $75 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Sylvania
- Ramalingam SelvarajahLondon$6K
- Angela GarlandCincinnati$4K
- Olusegun OdukoyaCleveland$2K
- Thomas SchmeiserTallmadge$823
- Charles KellerLogan$526
- Malini DesaiAkron$511
- Alexander CampoloNewark$505
- Tiffany SwainColumbus$448
- William SawyerCincinnati$443
- Malinda PowellLancaster$433
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.